Compass… phase 2B data, which has yet to be formally published in a peer-reviewed journal… with five patients (6.3%) in the 25-mg group and six patients (8%) in the 10-mg group experiencing serious adverse events during the follow-up period…. These adverse events included suicidal ideation and suicidal behavior. The first Phase 3 trial has been…
…because there’s a dimension of mind changing with psychedelics, it takes off all the fences and we are more open to think differently, or to take another path. I will go back to the example of the elephants who travel another path. This is something that you can see in MRIs. There are new connections…
In 2021 study it was recognised that high moisture and moderate temperatures are the ideal settings for mushroom growth, suggesting that droughts dry the soil, meaning that less plants and fungi have an opportunity to survive. Water transportation is pivotal to mycelium growth, and it is widely accepted that an increase in drought affects interactions…
…a new wave of research is exploring the therapeutic uses of other substances such as magic mushrooms, MDMA and LSD, not just as party drugs but as real-life neurotechnologies that can act as a chemical nudge on the brain systems involved in love and attachment. …let’s not forget, love itself is also not to be taken lightly. Instead of…
…researchers have built a virtual library of 75 million compounds related to these drugs. This approach yielded two molecules that showed antidepressant properties in mice, but without the hallucinogenic activity of psychedelic drugs. Original Article (Nature):Virtual library of LSD-like drugs could reveal new antidepressantsArtwork Fair Use: Jimmy-neutron
When controlling for confounding variables, the results revealed that lifetime psychedelic use was not associated with lifetime cancer diagnosis nor hematologic cancer diagnosis. This was true for each of the three classifications of psychedelics: tryptamine (5-MeO-DIPT, AMT, DMT), lysergamide (LSD), and phenethylamine (2C-B, mescaline, MDMA, peyote, and San Pedro). “Beginning in the late 1960s, concerns were raised by laboratory experiments that…
…people have… found that compounds such as psilocybin can have psychotherapeutic benefits. However, that has not addressed their evolution in nature… …scientists from the University of Plymouth are conducting a first-of-its-kind study using advanced genetic methods and behavioral experiments to address previously untested hypotheses into the origin of psychedelic compounds in fungi. Original Article (Phsy.org):Scientists to…
While there is always room for more research to be conducted, as of now, studies have shown that kratom has many benefits… kratom leaf has been chewed for at least 150 years in Southeast Asia… Kratom has been shown in studies to have antidepressant and appetite-suppressant properties. In one animal research, researchers discovered that kratom…
60 people participated in two psilocybin trials and had their fMRI brain scans analysed by scientists… scans were taken before and after treatment… The results showed that the psilocybin treatment reduced connections within brain areas that are tightly connected in depression. According to this research, scientists found that psilocybin rewires the brain for up to…
…in mice, MDMA can reopen the critical period for social learning after it should have closed permanently. In 2019, neuroscientist Gül Dölen’s laboratory at Johns Hopkins University in Baltimore, Maryland, found that the psychedelic drug MDMA resensitizes the brains of adult mice so they can learn from their social environment in a way that’s normally…
Recent Comments